David Andrews, MD
Pediatric Dermatology · Phoenix, AZNPI 1073860920
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,800 of the $12,194 with a category attached, or 80.4%. Verrica Pharmaceuticals Inc. accounts for 81.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $10,274 and has fallen 91.8% since, to $840 in 2025.
Across 49 payments — averaging $248.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Verrica Pharmaceuticals Inc.$10K
- Sanofi$1K
- Chiesi USA, Inc.$328
- AbbVie$237
- Novartis$83
- Pfizer$62
- plus $244 from 8 others
What the payments were for
- Consulting fees$8637%
- Speaking & faculty fees$9,80080%
- Travel & lodging$891%
- Food & beverage$1,44312%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Verrica Pharmaceuticals Inc. | 14 | $9,941 |
| Sanofi | 5 | $1,298 |
| Chiesi USA, Inc. | 2 | $328 |
| AbbVie | 11 | $237 |
| Novartis | 3 | $83 |
| Pfizer | 1 | $62 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Galderma Laboratories, L.p. | 3 | $47 |
| Organon | 2 | $33 |
| Regeneron | 1 | $28 |
| Botanix SB Inc | 1 | $24 |
| Krystal Biotech Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| LEO Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric dermatology providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 29 | $189 |
Paid to pharmacies, not to this prescriber.
Other pediatric dermatology in Phoenix
- Harper PricePhoenix$18K
- Daniela RussiPhoenix$11K
- Anna FigueiredoPhoenix$4K
- Elizabeth DupuyPhoenix$645
- Sierra WolterPhoenix$360
- Dana HarbPhoenix$337
- Fatmah AlzahraniPhoenix$199
- Karan LalScottsdale$644K
- Michelle JeffriesChandler$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.